The efficacy of photodynamic therapy (PDT) depends upon the delivery of both photosensitizing drug and oxygen. In this study, we hypothesized that local vascular microenvironment is a determinant of tumor response to PDT. Tumor vascularization and its basement membrane (collagen) were studied as a function of supplementation with basement membrane matrix (Matrigel) at the time of tumor cell inoculation. Effects on vascular composition with consequences to tumor hypoxia, photosensitizer uptake and PDT response were measured. Matrigel-supplemented tumors developed more normalized vasculature, composed of smaller and more uniformly-spaced blood vessels than their unsupplemented counterparts, but these changes did not affect tumor oxygenation or PDT-mediated direct cytotoxicity. However, PDT-induced vascular damage increased in Matrigel-supplemented tumors, following an affinity of the photosensitizer Photofrin for collagen-containing vascular basement membrane coupled with increased collagen content in these tumors. The more highly-collagenated tumors demonstrated more vascular congestion and ischemia after PDT, along with a higher probability of curative outcome that was collagen dependent. In the presence of photosensitizer-collagen localization, PDT effects on collagen were evidenced by a decrease in its association with vessels. Together, our findings demonstrate that photosensitizer localization to collagen increases vascular damage and improves treatment efficacy in tumors with greater collagen content. The vascular basement membrane is thus identified to be a determinant of therapeutic outcome in PDT of tumors.
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Abstract
The efficacy of photodynamic therapy (PDT) depends upon the delivery of both photosensitizing drug and oxygen. In this study, we hypothesized that local vascular microenvironment is a determinant of tumor response to PDT. Tumor vascularization and its basement membrane (collagen) were studied as a function of supplementation with basement membrane matrix (Matrigel) at the time of tumor cell inoculation. Effects on vascular composition with consequences to tumor hypoxia, photosensitizer uptake and PDT response were measured. Matrigel-supplemented tumors developed more normalized vasculature, composed of smaller and more uniformly-spaced blood vessels than their unsupplemented counterparts, but these changes did not affect tumor oxygenation or PDT-mediated direct cytotoxicity. However, PDT-induced vascular damage increased in Matrigel-supplemented tumors, following an affinity of the photosensitizer Photofrin for collagen-containing vascular basement membrane coupled with increased collagen content in these tumors. The more highly-collagenated tumors demonstrated more vascular congestion and ischemia after PDT, along with a higher probability of curative outcome that was collagen dependent. In the presence of photosensitizer-collagen localization, PDT effects on collagen were evidenced by a decrease in its association with vessels. Together, our findings demonstrate that photosensitizer localization to collagen increases vascular damage and improves treatment efficacy in tumors with greater collagen content. The vascular basement membrane is thus identified to be a determinant of therapeutic outcome in PDT of tumors.
Introduction
Tumor microenvironment is a variable to be contended with in the delivery of chemotherapy, radiation, and photodynamic therapy, among other therapeutic modalities (1, 2) . Tumor vascularization is especially important in photodynamic therapy (PDT), which relies on blood vessels to deliver the molecular oxygen and photosensitizing drugs that are required for a successful outcome to typically applied protocols. Yet, a chaotic vascular network in many tumors limits drug and oxygen delivery (3) (4) (5) . Heterogeneities in both photosensitizer levels and oxygen concentrations have been documented within and between tumors in preclinical and clinical studies (6) (7) (8) (9) (10) . Moreover, use of approaches to adjust for these heterogeneities has met with success in improving treatment outcome (11) (12) (13) .
Several investigations demonstrate effects of tumor microenvironment on PDT.
Chen et al (14) studied rat prostate tumors grown in orthotopic vs. subcutaneous sites,
showing that tumors grown in the prostate exhibited a higher vascular density and lower hypoxic fractions than those in subcutaneous tissue. This improvement in oxygenation was accompanied by greater PDT-mediated cytotoxicity in the prostate-localized tumors. Others showed the rate of photosensitizer diffusion through tumors of the same cell line to differ as a function of the anatomical site of their propagation, suggesting a role for tumor microenvironment in photosensitizer uptake and distribution (15) . The significance of the tumor stroma in PDT was considered in a review by Peng and Nesland (16) , who noted an affinity of photosensitizers for collagen, which could lead to differences in photosensitizer uptake among tumors as a function of their stromal composition. The effects of vascular microenvironment on tumor oxygenation, photosensitizer concentrations and localization, and PDT-created vascular damage were measured.
From these studies, we have identified an in vivo role for collagen IV, a component of the tumor basement membrane, in determining the response of tumor vasculature to PDT.
Materials and Methods
Tumor Models
H460 cells were purchased from ATCC, while RIF and SCCVII cells originated from the lines produced by Twentyman et al (18) and O'Malley et al (19) , respectively. Membrane Matrix (4.5 mg/ml; BD Bioscience, San Jose, CA) added to the tumor cell suspension. Animals were studied ~7-10 days later when tumors were 5-7 mm in diameter. Fur in C3H mice was clipped and the treatment area depilated at least 24h before illumination. 
Immunohistochemistry
Tumor blood vessels and basement membrane were identified by staining of frozen sections (14μm) with antibodies to CD31 (BD Pharmingen, San Diego, CA) and collagen (Millipore Corporation, Temecula, CA), respectively. After ethanol fixation sections were stained for collagen (1:40 for 1h) and CD31 (1:100 for 1h) as previously described (20) , with the exception that rabbit serum replaced milk and bovine serum albumin in collagen staining. Respective to the collagen and CD31 antibodies, 
In vivo/in vitro clonogenic assay
Excised tumors were weighed, minced, and enzymatically digested over 30 min (37 o C) as previously described (22) . The number of clonogenic cells per g was calculated as the number of cells per g times the ratio of the number of colonies counted to the number plated. 
Photosensitizer distribution and concentration
Fluorescence microscopy (see Supplementary Material) for Photofrin was performed immediately after sectioning. Sections were then stained (see Immunohistochemistry) and re-photographed at the same coordinates. From masks of CD31, collagen and Photofrin, vascular "objects" with Photofrin colocalization were analyzed for their % coverage by Photofrin (MATLAB). The extent of Photofrin colocalization was compared between "objects" consisting of CD31-stained vasculature and those consisting of collagenated vasculature identified by both CD31 and collagen staining.
Tumor concentrations of Photofrin were quantified using spectrofluorometric assay (23), as we have previously described (8) .
Diffuse correlation spectroscopy
Tumor relative blood flow during PDT was measured using diffuse correlation 
Tumor response
Mice were followed after PDT until tumor volumes >400 mm 3 (RIF and SCCVII)
or pre-treatment volume (H460). Volume was measured in two orthogonal directions (volume = diameter x width 2 x 3.14/6). A cure was defined as an absence of tumor regrowth at 90 days after PDT.
Confocal microscopy
Frozen sections (20 μm) collected immediately after PDT were stained for CD31
and collagen (see Differences in immunohistochemical or histological staining between naïve and Matrigel-supplemented tumors were compared using t-tests assuming unequal variance, as were differences in photosensitizer content and tumor blood flow. Paired t-tests were used to compare the extent of Photofrin colocalization with CD31-labeled blood vessels vs. the collagen-containing areas on these vessels. Analyses were performed in JMP (SAS Institute, Inc; Cary, NC) with p < 0.05 considered significant.
Results
Matrigel-altered tumor microenvironment doesn't change PDT-mediated direct tumor cytotoxicity
Tumors with an altered vascular microenvironment were grown without changing the malignant cell type or anatomic location of propagation by supplementing the cell inoculum with Matrigel. Compared to unsupplemented (naïve) RIF tumors, Matrigelsupplemented tumors were more consistently vascularized (note the avascular strip in the RIF tumor of Fig 1A) . Overall, RIF-Matrigel tumors contained significantly less vascular area (Fig 1B) , which could be attributed to a small decrease in vessel size (not shown) and a significant reduction in the vascular density (Fig 1C) . These changes are consistent with vascular normalization (25) .
Following observations of more consistent vascularization in RIF-Matrigel tumors, intervascular distance (median) was measured in RIF (42 μm) and RIF-Matrigel tumors (44 μm), but found to be indistinguishable between the tumor types ( Fig 1D) . In contrast, variability in intervascular spacing was much larger in RIF tumors, and, accordingly, the coefficient of variation was significantly (p = 0.016) higher in these tumors (28 ± 3% vs. vascularization may affect oxygenation, hypoxia was labeled by EF3. Both models exhibited more EF3 binding (mean ± SE) than nonspecific background (3.57 ± 0.34), but no differences were found between RIF-Matrigel (29 ± 8) and RIF tumors (32 ± 6). Any improvement in tumor oxygenation could increase direct PDT cytotoxicity (11) so the in vivo/in vitro clonogenic assay was used to measure cell death immediately after treatment. Mean (± SE) clonogenic survivals were 2.12 ± 0.9e7 and 1.47 ± 0.5e7 clonogenic cells/g in RIF and RIF-Matrigel tumors, respectively. Thus, in addition to the EF3 data, the absence of a differential in direct PDT-mediated cytotoxicity suggests that changes in the vascular status of RIF-Matrigel tumors didn't improve their oxygenation.
Photosensitizer localization is affected by microenvironment
Vascular normalization can affect uptake or retention of therapeutic drugs (26) , leading us to next assess Photofrin distributions at the gross and microscopic levels. 
was restricted to vessel areas that contained collagen IV, a component of vascular basement membrane (Fig 3A) . By paired analysis, Photofrin associated significantly (p<0.001) better with collagen-containing areas of blood vessels compared to the entire vessel. Because collagen is a major component of Matrigel, the collagen composition of RIF and RIF-Matrigel tumors was compared. Collagen was more prominent in RIFMatrigel tumors (Fig 3B) with an average (±SE) content of 9.3 ± 1.2% in RIF-Matrigel tumors vs. 4.9 ± 0.5% in RIF tumors (p=0.007) (Fig 3C) .
Vascular response to PDT is enhanced in a more highly-collagenated tumor microenvironment
The preferred association of photosensitizer with collagenated areas on blood vessels (in Fig 3A) , together with the increased collagen content of Matrigelsupplemented RIF tumors (in Fig 3C) led us to suspect that the Matrigel-altered microenvironment would have increased susceptibility to PDT-mediated vascular damage. To test if vascular response differed as a function of microenvironment, DCS was used to follow tumor hemodynamics during PDT. After an acute increase, blood flow decreased during PDT (Fig 4A) , in agreement with our previous report (24) in RIF vs. RIF-Matrigel tumors, respectively, which documents a significant decrease (p= 0.02) in the intratumoral heterogeneity of vascular response in RIF-Matrigel tumors.
A more homogeneous vascular response in the more highly-collagenated RIFMatrigel tumors could be mediated through collagen's role as a substrate in the coagulation cascade (27) . PDT can activate this cascade, causing vascular congestion and fibrin accumulation in vivo (28, 29) . In both naïve and Matrigel-supplemented tumors, PDT-created vascular congestion with accompanying fibrin accumulation was detectable by H&E ( Supplementary Fig. S2 ). RIF-Matrigel tumors had a significantly larger (p=0.029) congested area (mean ± SE) of 10.5 ± 1.0% (vs. 6.2 ± 0.9% in RIF tumors; Fig 4B,C) , and significantly (p=0.03) greater ischemia after treatment (Fig 4D) .
Tumor response studies confirmed the therapeutic significance of the stronger vascular response in RIF-Matrigel tumors (Fig 4E) . Whereas all RIF tumors regrew within 24 days, 25% of RIF-Matrigel tumors didn't recur (tumor cures). It is noteworthy that PDT was less effective in RIF tumors despite their higher photosensitizer levels. This is consistent with the observed ineffective distribution of photosensitizer to avascular areas (see Fig 2) . Conversely, lower gross levels of photosensitizer in RIFMatrigel tumors weren't prohibitive of a robust vascular and curative tumor response, pointing to the significance of photosensitizer localization to these results. 13 collagen content affected response when photosensitizer localization to collagen didn't occur, Photofrin-PDT (2.5 mg/kg) was performed with a short drug-light interval. No tumor or stromal localization of Photofrin was detectable after 30 minutes (Fig 5A) , in contrast to results with standard (24h) incubation (Fig 5A, inset) . PDT of RIF tumors to 75 J/cm 2 with a short drug-light interval produced a regrowth delay of up to 21 days, similar to that reported above for standard PDT. However, unlike that found with standard PDT, RIF-Matrigel tumors weren't more responsive than RIF tumors when drug-light interval was short. A curative light dose (135 J/cm 2 ) at short drug-light interval also failed to differentially affect response in RIF vs. RIF-Matrigel tumors (Fig 5B) .
Thus, the extravascular distribution of Photofrin, including to basement membrane, is necessary for tumors to differentially benefit from PDT when they are more-highly collagenated. It points to a role for PDT effect on collagen in mediating increases in vascular damage in Matrigel-supplemented tumors.
The absence of a differential response between RIF and RIF-Matrigel tumors to PDT with short drug-light interval also provides evidence that Matrigel doesn't impart therapeutic advantage to PDT independent of vascular response. To independently confirm this finding, we studied H460 tumors, which unlike RIF, demonstrate high collagen content in their naïve form (12.8 ± 1.7%). The strength and distribution of collagen staining in H460 tumors ( Supplementary Fig. S3A ), reflects that seen in RIFMatrigel tumors (see Fig 1A) , and no measureable increase in collagen accompanied the addition of Matrigel to H460 tumors (13.7 ± 0.7%). H460 tumors had an 18% cure rate to Photofrin-PDT and the addition of Matrigel didn't improve response, further confirming that Matrigel itself didn't inherently benefit PDT (Fig S3B) . 
PDT alters collagen expression
Having defined a role for Photofrin localization to collagen as a determinant of tumor response in RIF tumors, SCCVII tumors were evaluated in confirmatory studies that investigated PDT effect on collagen. SCVVII-Matrigel tumors demonstrated collagen levels similar to RIF-Matrigel tumors, i.e. 9.0 ± 1.5% vs. 9.3 ± 1.2%, respectively, which was, on average, more collagen then the 6.7 ± 0.7% found in naïve SCVVII tumors (Fig 6A) . As expected, Photofrin was significantly (p = 0.003) better associated with collagenated areas of blood vessels than with the entire structure ( Fig   6B) . Moreover, as found in the RIF models, SCCVII-Matrigel tumors were more responsive to PDT than their naïve counterparts (Fig 6C) , with a cure rate of 57% in the Matrigel-supplemented vs. 0% in naïve tumors, respectively.
Given the high response rate of SCCVII-Matrigel tumors, this model was employed for further investigation of PDT effect on vessel structure. Using confocal microscopy, vessels were identified as areas of collagen and CD31 colocalization. A representative micrograph (Fig 6D) illustrates a control tumor with CD31-labeled blood vessels (red) that were well-covered by collagen (green). Contrastingly, in tumors that received PDT, areas of vasculature that lack collagen coverage were more prominent.
The inset of Fig 6D plots the overlap coefficient (k) , which quantifies the contribution of signal from one channel (i.e. collagen) to its colocalization with another channel (i.e. In the anatomy of a blood vessel, basement membrane provides structural support abluminal to endothelial cells and separates these cells from underlying stroma (33) . Damage to endothelial cells can expose basement membrane, triggering the coagulation cascade through complexes of platelets and vonWillebrand factor that bind to exposed collagen (27) . Tumors are commonly characterized by inconsistencies in the endothelial cell layer, which can make them more prone to such damage (26) 
